BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28969383)

  • 1. A ventral glomerular deficit in Parkinson's disease revealed by whole olfactory bulb reconstruction.
    Zapiec B; Dieriks BV; Tan S; Faull RLM; Mombaerts P; Curtis MA
    Brain; 2017 Oct; 140(10):2722-2736. PubMed ID: 28969383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.
    Huisman E; Uylings HB; Hoogland PV
    Mov Disord; 2008 Jul; 23(10):1407-13. PubMed ID: 18581481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misrouted olfactory fibres and ectopic olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients.
    Hoogland PV; van den Berg R; Huisman E
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):303-11. PubMed ID: 12787327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Mohedano-Moriano A; Fradejas N; Calvo S; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Mov Disord; 2010 Aug; 25(11):1701-7. PubMed ID: 20574962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
    Huisman E; Uylings HB; Hoogland PV
    Mov Disord; 2004 Jun; 19(6):687-92. PubMed ID: 15197709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-synuclein inclusions are abundant in non-neuronal cells in the anterior olfactory nucleus of the Parkinson's disease olfactory bulb.
    Stevenson TJ; Murray HC; Turner C; Faull RLM; Dieriks BV; Curtis MA
    Sci Rep; 2020 Apr; 10(1):6682. PubMed ID: 32317654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy.
    Chen S; Tan HY; Wu ZH; Sun CP; He JX; Li XC; Shao M
    Eur J Radiol; 2014 Mar; 83(3):564-70. PubMed ID: 24360232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
    Petit GH; Berkovich E; Hickery M; Kallunki P; Fog K; Fitzer-Attas C; Brundin P
    PLoS One; 2013; 8(4):e60691. PubMed ID: 23573275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of tau causes an olfactory deficit in a murine model of Parkinson's disease.
    Beauchamp LC; Chan J; Hung LW; Padman BS; Vella LJ; Liu XM; Coleman B; Bush AI; Lazarou M; Hill AF; Jacobson L; Barnham KJ
    Acta Neuropathol Commun; 2018 Jul; 6(1):57. PubMed ID: 29976255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study.
    Mueller A; Abolmaali ND; Hakimi AR; Gloeckler T; Herting B; Reichmann H; Hummel T
    J Neural Transm (Vienna); 2005 Oct; 112(10):1363-70. PubMed ID: 15711853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of olfactory function with olfactory bulbus volume, disease duration and Unified Parkinson's disease rating scale scores in patients with early stage of idiopathic Parkinson's disease.
    Hakyemez HA; Veyseller B; Ozer F; Ozben S; Bayraktar GI; Gurbuz D; Cetin S; Yildirim YS
    J Clin Neurosci; 2013 Oct; 20(10):1469-70. PubMed ID: 23870619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.
    Zhang S; Xiao Q; Le W
    PLoS One; 2015; 10(3):e0119928. PubMed ID: 25799501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomorphological Changes in the Olfactory Bulbs of Rats after Intranasal Administration of Rotenone.
    Voronkov DN; Kutukova KA; Ivanov MV; Khudoerkov RM
    Bull Exp Biol Med; 2017 Dec; 164(2):203-206. PubMed ID: 29181664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.
    Cersosimo MG
    Cell Tissue Res; 2018 Jul; 373(1):233-243. PubMed ID: 29196808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
    Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
    Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.
    Doorn KJ; Goudriaan A; Blits-Huizinga C; Bol JG; Rozemuller AJ; Hoogland PV; Lucassen PJ; Drukarch B; van de Berg WD; van Dam AM
    Brain Pathol; 2014 Mar; 24(2):152-65. PubMed ID: 24033473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.
    Skorpil M; Söderlund V; Sundin A; Svenningsson P
    J Parkinsons Dis; 2012; 2(2):171-80. PubMed ID: 23939442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.